Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-12-02

Clinical Trial Update: Open Trial of Escitalopram Treatment for Male Subjects With Posttraumatic Stress Disorder [NA]

View source ↗

Summary

Open trial investigating escitalopram for male subjects with posttraumatic stress disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

Sponsor: Northern California Institute of Research and Education | Conditions: Chronic Posttraumatic Stress Disorder | NA | Status: COMPLETED